Regulation 257D Guidance as to packaging and package leafletsF1

( 1)

The licensing authority may publish guidance on packaging and package leaflets applicable to products for sale or supply in the whole United Kingdom or parts of the United Kingdom, as appropriate.

(2)

Guidance published under paragraph (1) may, in particular, include—

(a)

the wording of certain special warnings for certain categories of medicinal products;

(b)

the particular information needs relating to products that are a pharmacy medicine;

(c)

the legibility of particulars on the labelling and package leaflet;

(d)

the methods of identification and authentication of medicinal products;

(e)

the list of excipients which must feature on the labelling of medicinal products and the way in which these excipients must be indicated.

(3)

Until such time as the licensing authority publishes guidance under paragraph (1), any guidance published by the Commission pursuant to Article 65 of the 2001 Directive, insofar as that guidance was in force immediately before IP completion day, continues to apply as if it had been published by the licensing authority under paragraph (1).

Annotations

Textual amendments

F1: Regs. 257C-257E inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 200 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 154); 2020 c. 1, Sch. 5 para. 1(1)